Orexin modulation of adipose tissue

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 3, 2014, Pages 440-445

  Perez Leighton, Claudio E ^a,c,d   Billington, Charles J ^b,c   Kotz, Catherine M ^a,c  

^a GRECC   (United States)

^b Veterans Administration Health Care System   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

Adipose tissue; Brain; Energy expenditure; Orexin

Indexed keywords

OREXIN;

ADIPOSE TISSUE; BROWN ADIPOSE TISSUE; CALORIC INTAKE; ENERGY BALANCE; ENERGY EXPENDITURE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; WHITE ADIPOSE TISSUE;

RODENTIA;

ADIPOSE TISSUE; BRAIN; ENERGY EXPENDITURE; OREXIN;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; CENTRAL NERVOUS SYSTEM; ENERGY METABOLISM; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; OBESITY;

EID: 84893685572     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.06.007     Document Type: Review

References (92)

1. Tsujino N., Sakurai T. Orexin/Hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol. Rev. 2009, 61:162-176.
2. Aston-Jones G., Smith R.J., Moorman D.E., Richardson K.A. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 2009, 56(Suppl. 1):112-121.
3. Brown R.M., Lawrence A.J. Ascending orexinergic pathways and alcohol-seeking. Curr. Opin. Neurobiol. 2013, 13:62-67.
4. Cason A.M., Smith R.J., Tahsili-Fahadan P., Moorman D.E., Sartor G.C., Aston-Jones G. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol. Behav. 2010, 100:419-428.
5. Kotz C., Nixon J., Butterick T., Perez-Leighton C., Teske J., Billington C. Brain orexin promotes obesity resistance. Ann. N. Y. Acad. Sci. 2012, 1264:72-86.
6. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
7. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:322-327.
8. Adamantidis A., de Lecea L. The hypocretins as sensors for metabolism and arousal. J. Physiol. 2009, 587:33-40.
9. Novak C.M., Levine J.A. Daily intraparaventricular orexin-A treatment induces weight loss in rats. Obesity 2009, 17:1493-1498.
10. Mavanji V., Teske J.A., Billington C.J., Kotz C.M. Elevated sleep quality and orexin receptor mRNA in obesity-resistant rats. Int. J. Obes. (Lond) 2010, 34:1576-1588.
11. Garland T., Schutz H., Chappell M.A., Keeney B.K., Meek T.H., Copes L.E., Acosta W., Drenowatz C., Maciel R.C., van Dijk G., Kotz C.M., Eisenmann J.C. The biological control of voluntary exercise, spontaneous physical activity and daily energy expenditure in relation to obesity: human and rodent perspectives. J. Exp. Biol. 2011, 214:206-229.
12. Nixon J.P., Kotz C.M., Novak C.M., Billington C.J., Teske J.A. Neuropeptides controlling energy balance: orexins and neuromedins. Handb. Exp. Pharmacol. 2012, 77-109.
13. Perez-Leighton C.E., Butterick-Peterson T.A., Billington C.J., Kotz C.M. Role of orexin receptors in obesity: from cellular to behavioral evidence. Int. J. Obes. (Lond) 2013, 37:167-174.
14. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., Sugiyama F., Yagami K., Goto K., Yanagisawa M., Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001, 30:345-354.
15. Teske J.A., Levine A.S., Kuskowski M., Levine J.A., Kotz C.M. Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R889-R899.
16. Funato H., Tsai A.L., Willie J.T., Kisanuki Y., Williams S.C., Sakurai T., Yanagisawa M. Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab. 2009, 9:64-76.
17. Bartness T.J., Song C.K. Brain-adipose tissue neural crosstalk. Physiol. Behav. 2007, 91:343-351.
18. Bartness T.J., Song C.K. Thematic review series: adipocyte biology. Sympathetic and sensory innervation of white adipose tissue 2007, 48:1655-1672.
19. Henry B.A., Clarke I.J. Adipose tissue hormones and the regulation of food intake. J. Neuroendocrinol. 2008, 20:842-849.
20. Nixon J.P., Smale L. A comparative analysis of the distribution of immunoreactive orexin A and B in the brains of nocturnal and diurnal rodents. Behav. Brain Funct. 2007, 3:28.
21. Ammoun S., Holmqvist T., Shariatmadari R., Oonk H.B., Detheux M., Parmentier M., Akerman K.E., Kukkonen J.P. Distinct recognition of OX1 and OX2 receptors by orexin peptides. J. Pharmacol. Exp. Ther. 2003, 305:507-514.
22. Schone C., Venner A., Knowles D., Karnani M.M., Burdakov D. Dichotomous cellular properties of mouse orexin/hypocretin neurons. J. Physiol. 2011, 589:2767-2779.
23. Karnani M.M., Apergis-Schoute J., Adamantidis A., Jensen L.T., de Lecea L., Fugger L., Burdakov D. Activation of central orexin/hypocretin neurons by dietary. Amino Acids 2011, 72:616-629.
24. Diano S., Horvath B., Urbanski H.F., Sotonyi P., Horvath T.L. Fasting activates the nonhuman primate hypocretin (orexin) system and its postsynaptic targets. Endocrinology 2003, 144:3774-3778.
25. Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., Tominaga M., Yagami K., Sugiyama F., Goto K., Yanagisawa M., Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003, 38:701-713.
26. Williams R.H., Alexopoulos H., Jensen L.T., Fugger L., Burdakov D. Adaptive sugar sensors in hypothalamic feeding circuits. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11975-11980.
27. Edwards C.M., Abusnana S., Sunter D., Murphy K.G., Ghatei M.A., Bloom S.R. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J. Endocrinol. 1999, 160:R7-R12.
28. Sakurai T., Nagata T., Yamanaka A., Kawamura H., Tsujino N., Muraki Y., Kageyama H., Kunita S., Takahashi S., Goto K., Koyama Y., Shioda S., Yanagisawa M. Input oforexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 2005, 46:297-308.
29. Leinninger G.M., Jo Y.H., Leshan R.L., Louis G.W., Yang H., Barrera J.G., Wilson H., Opland D.M., Faouzi M.A., Gong Y., Jones J.C., Rhodes C.J., Chua S., Diano S., Horvath T.L., Seeley R.J., Becker J.B., Munzberg H., Myers M.G. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metab. 2009, 10:89-98.
30. Guan J.L., Uehara K., Lu S., Wang Q.P., Funahashi H., Sakurai T., Yanagizawa M., Shioda S. Reciprocal synaptic relationships between orexin- and melanin-concentrating hormone-containing neurons in the rat lateral hypothalamus: a novel circuit implicated in feeding regulation. Int. J. Obes. Relat. Metab. Disord. 2002, 26:1523-1532.
31. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 1998, 18:9996-10015.
32. Taheri S., Gardiner J., Hafizi S., Murphy K., Dakin C., Seal L., Small C., Ghatei M., Bloom S. Orexin A immunoreactivity and preproorexin mRNA in the brain of Zucker and WKY rats. Neuroreport 2001, 12:459-464.
33. Kotz C.M., Teske J.A., Billington C.J. Neuroregulation of nonexercise activity thermogenesis and obesity resistance. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294:R699-R710.
34. Perez-Leighton C.E., Boland K., Billington C.J., Kotz C.M. High and low activity rats: elevated intrinsic physical activity drives resistance to diet-induced obesity in non-bred rats. Obesity 2013, 21:353-360.
35. Kotz C.M. Integration of feeding and spontaneous physical activity: role for orexin. Physiol. Behav. 2006, 88:294-301.
36. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., Sakurai T., Yanagisawa M., Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:748-753.
37. van den Pol A.N., Gao X.B., Obrietan K., Kilduff T.S., Belousov A.B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J. Neurosci. 1998, 18:7962-7971.
38. Lubkin M., Stricker-Krongrad A. Independent feeding and metabolic actions of orexins in mice. Biochem. Biophys. Res. Commun. 1998, 253:241-245.
39. Perez-Leighton C.E., Boland K., Teske J.A., Billington C., Kotz C.M. Behavioral responses to orexin, orexin receptor gene expression and intrinsic physical activity contribute to individual sensitivity to obesity. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E865-E874.
40. Tafti M. Reply to 'Promotion of sleep by targeting the orexin system in rats, dogs and humans'. Nat. Med. 2007, 13:525-526. (author reply 526).
41. Brisbare-Roch C., Dingemanse J., Koberstein R., Hoever P., Aissaoui H., Flores S., Mueller C., Nayler O., van Gerven J., de Haas S.L., Hess P., Qiu C., Buchmann S., Scherz M., Weller T., Fischli W., Clozel M., Jenck F. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat. Med. 2007, 13:150-155.
42. Schuld A., Blum W.F., Pollmacher T. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann. Neurol. 2002, 51:660. (author reply 660-661).
43. Nishino S., Ripley B., Overeem S., Nevsimalova S., Lammers G.J., Vankova J., Okun M., Rogers W., Brooks S., Mignot E. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann. Neurol. 2001, 50:381-388.
44. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000, 27:469-474.
45. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., Li R., Hungs M., Pedrazzoli M., Padigaru M., Kucherlapati M., Fan J., Maki R., Lammers G.J., Bouras C., Kucherlapati R., Nishino S., Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 2000, 6:991-997.
46. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000, 355:39-40.
47. Adam J.A., Menheere P.P., van Dielen F.M., Soeters P.B., Buurman W.A., Greve J.W. Decreased plasma orexin-A levels in obese individuals. Int. J. Obes. Relat. Metab. Disord. 2002, 26:274-276.
48. Bronsky J., Nedvidkova J., Krasnicanova H., Vesela M., Schmidtova J., Koutek J., Kellermayer R., Chada M., Kabelka Z., Hrdlicka M., Nevoral J., Prusa R. Changes of orexin A plasma levels in girls with anorexia nervosa during eight weeks of realimentation. Int. J. Eat. Disord. 2011, 44:547-552.
49. Johren O., Neidert S.J., Kummer M., Dendorfer A., Dominiak P. Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 2001, 142:3324-3331.
50. Nakabayashi M., Suzuki T., Takahashi K., Totsune K., Muramatsu Y., Kaneko C., Date F., Takeyama J., Darnel A.D., Moriya T., Sasano H. Orexin-A expression in human peripheral tissues. Mol. Cell. Endocrinol. 2003, 205:43-50.
51. Digby J.E., Chen J., Tang J.Y., Lehnert H., Matthews R.N., Randeva H.S. Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B. J. Endocrinol. 2006, 191:129-136.
52. Skrzypski M., T.L.T, Kaczmarek P., Pruszynska-Oszmalek E., Pietrzak P., Szczepankiewicz D., Kolodziejski P.A., Sassek M., Arafat A., Wiedenmann B., Nowak K.W., Strowski M.Z. Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes. Diabetologia 2011, 54:1841-1852.
53. Bamshad M., Aoki V.T., Adkison M.G., Warren W.S., Bartness T.J. Central nervous system origins of the sympathetic nervous system outflow to white adipose tissue. Am. J. Physiol. 1998, 275:R291-R299.
54. Stanley S., Pinto S., Segal J., Perez C.A., Viale A., DeFalco J., Cai X., Heisler L.K., Friedman J.M. Identification of neuronal subpopulations that project from hypothalamus to both liver and adipose tissue polysynaptically. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7024-7029.
55. van den Pol A.N. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J. Neurosci. 1999, 19:3171-3182.
56. Adler E.S., Hollis J.H., Clarke I.J., Grattan D.R., Oldfield B.J. Neurochemical characterization and sexual dimorphism of projections from the brain to abdominal and subcutaneous white adipose tissue in the rat. J. Neurosci. 2012, 32:15913-15921.
57. de Lecea L., Sutcliffe J.G., Fabre V. Hypocretins/orexins as integrators of physiological information: lessons from mutant animals. Neuropeptides 2002, 36:85-95.
58. Kampe J., Tschop M.H., Hollis J.H., Oldfield B.J. An anatomic basis for the communication of hypothalamic, cortical and mesolimbic circuitry in the regulation of energy balance. Eur. J. Neurosci. 2009, 30:415-430.
59. Shen J., Tanida M., Yao J.F., Niijima A., Nagai K. Biphasic effects of orexin-A on autonomic nerve activity and lipolysis. Neurosci. Lett. 2008, 444:166-171.
60. Yamanaka A., Tsujino N., Funahashi H., Honda K., Guan J.L., Wang Q.P., Tominaga M., Goto K., Shioda S., Sakurai T. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem. Biophys. Res. Commun. 2002, 290:1237-1245.
61. Schone C., Cao Z.F., Apergis-Schoute J., Adamantidis A., Sakurai T., Burdakov D. Optogenetic probing of fast glutamatergic transmission from hypocretin/orexin to histamine neurons in situ. J. Neurosci. 2012, 32:12437-12443.
62. Bayer L., Eggermann E., Serafin M., Saint-Mleux B., Machard D., Jones B., Muhlethaler M. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur. J. Neurosci. 2001, 14:1571-1575.
63. Eriksson K.S., Sergeeva O., Brown R.E., Haas H.L. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J. Neurosci. 2001, 21:9273-9279.
64. Tsuda K., Yoshimatsu H., Niijima A., Chiba S., Okeda T., Sakata T. Hypothalamic histamine neurons activate lipolysis in rat adipose tissue. Exp. Biol. Med. (Maywood) 2002, 227:208-213.
65. Bartness T.J. Dual innervation of white adipose tissue: some evidence for parasympathetic nervous system involvement. J. Clin. Invest. 2002, 110:1235-1237.
66. Berthoud H.R., Fox E.A., Neuhuber W.L. Vagaries of adipose tissue innervation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R1240-R1242.
67. Giordano A., Song C.K., Bowers R.R., Ehlen J.C., Frontini A., Cinti S., Bartness T.J. White adipose tissue lacks significant vagal innervation and immunohistochemical evidence of parasympathetic innervation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R1243-R1255.
68. Kreier F., Buijs R.M. Evidence for parasympathetic innervation of white adipose tissue, clearing up some vagaries. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R548-R549. (author reply R550-542, discussion R553-544).
69. Kreier F., Fliers E., Voshol P.J., Van Eden C.G., Havekes L.M., Kalsbeek A., Van Heijningen C.L., Sluiter A.A., Mettenleiter T.C., Romijn J.A., Sauerwein H.P., Buijs R.M. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat-functional implications. J. Clin. Invest. 2002, 110:1243-1250.
70. Morrison S.F., Madden C.J., Tupone D. Central control of brown adipose tissue thermogenesis 2012, 3.
71. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 2004, 84:277-359.
72. Krauss S., Zhang C.Y., Lowell B.B. The mitochondrial uncoupling-protein homologues, Nature reviews. Mol. Cell Biol. 2005, 6:248-261.
73. Liu X., Rossmeisl M., McClaine J., Riachi M., Harper M.E., Kozak L.P. Paradoxical resistance to diet-induced obesity in UCP1-deficient mice. J. Clin. Invest. 2003, 111:399-407.
74. Baffy G., Zhang C.Y., Glickman J.N., Lowell B.B. Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 2002, 35:753-761.
75. Vidal-Puig A.J., Grujic D., Zhang C.Y., Hagen T., Boss O., Ido Y., Szczepanik A., Wade J., Mootha V., Cortright R., Muoio D.M., Lowell B.B. Energy metabolism in uncoupling protein 3 gene knockout mice. J. Biol. Chem. 2000, 275:16258-16266.
76. Enerback S., Jacobsson A., Simpson E.M., Guerra C., Yamashita H., Harper M.E., Kozak L.P. Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 1997, 387:90-94.
77. Clapham J.C., Arch J.R., Chapman H., Haynes A., Lister C., Moore G.B., Piercy V., Carter S.A., Lehner I., Smith S.A., Beeley L.J., Godden R.J., Herrity N., Skehel M., Changani K.K., Hockings P.D., Reid D.G., Squires S.M., Hatcher J., Trail B., Latcham J., Rastan S., Harper A.J., Cadenas S., Buckingham J.A., Brand M.D., Abuin A. Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 2000, 406:415-418.
78. Sellayah D., Bharaj P., Sikder D. Orexin is required for brown adipose tissue development, differentiation, and function 2011, 14:478-490.
79. Bartness T.J., Vaughan C.H., Song C.K. Sympathetic and sensory innervation of brown adipose tissue 2010, 34(Suppl. 1):S36-S42.
80. Maclean P.S., Bergouignan A., Cornier M.A., Jackman M.R. Biology's response to dieting: the impetus for weight regain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:R581-R600.
81. Tupone D., Madden C.J., Cano G., Morrison S.F. An orexinergic projection from perifornical hypothalamus to raphe pallidus increases rat brown adipose tissue thermogenesis. J. Neurosci. 2011, 31:15944-15955.
82. Oldfield B.J., Allen A.M., Davern P., Giles M.E., Owens N.C. Lateral hypothalamic 'command neurons' with axonal projections to regions involved in both feeding and thermogenesis. Eur. J. Neurosci. 2007, 25:2404-2412.
83. Bamshad M., Song C.K., Bartness T.J. CNS origins of the sympathetic nervous system outflow to brown adipose tissue 1999, 276:R1569-R1578.
84. Berthoud H.R., Patterson L.M., Sutton G.M., Morrison C., Zheng H. Orexin inputs to caudal raphe neurons involved in thermal, cardiovascular, and gastrointestinal regulation. Histochem. Cell Biol. 2005, 123:147-156.
85. Berthoud H.R., Morrison C. The brain, appetite, and obesity. Annu. Rev. Psychol. 2008, 59:55-92.
86. Billington C.J., Briggs J.E., Harker S., Grace M., Levine A.S. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism 1994, 266:R1765-R1770.
87. Kenney M.J., Weiss M.L., Haywood J.R. The paraventricular nucleus: an important component of the central neurocircuitry regulating sympathetic nerve outflow. Acta Physiol. Scand. 2003, 177:7-15.
88. Liu Z.-W., Gan G., Suyama S., Gao X.-B. Intracellular energy status regulates activity in hypocretin/orexin neurones: a link between energy and behavioural states 2011, 589:4157-4166.
89. Burt J., Alberto C.O., Parsons M.P., Hirasawa M. Local Network Regulation of Orexin Neurons in the Lateral Hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:R572-R580.
90. Akiyama M., Yuasa T., Hayasaka N., Horikawa K., Sakurai T., Shibata S. Reduced food anticipatory activity in genetically orexin (hypocretin) neuron-ablated mice. Eur. J. Neurosci. 2004, 20:3054-3062.
91. Mieda M., Williams S.C., Sinton C.M., Richardson J.A., Sakurai T., Yanagisawa M. Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness. J. Neurosci. 2004, 24:10493-10501.
92. Mistlberger R.E., Antle M.C., Kilduff T.S., Jones M. Food- and light-entrained circadian rhythms in rats with hypocretin-2-saporin ablations of the lateral hypothalamus. Brain Res. 2003, 980:161-168.